This is the authors' abstract. We don't add key points for this paper.
, in feces) have excellent capabilities to improve different aspects of management of HCC. Numerous studies have been devoted in identifying more promising candidate biomarkers and therapeutic targets for diagnosis, treatment, and monitoring responses of HCC to conventional therapies, most of which may improve diagnosis and management of HCC in the future. This review aimed to summarize recent advances in utilizing these biomarkers in HCC and discuss their clinical significance.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Guan et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: